cdmo.directory
← Home
WuXi Vaccines logo

WuXi Vaccines

End-to-end vaccine and prophylactic antibody CDMO with global GMP-certified facilities.

Global CDMO specializing in end-to-end vaccine and prophylactic antibody development and manufacturing across mammalian, viral, and microbial platforms with GMP-certified facilities and over 550 million doses delivered. Headquartered in Suzhou, China.

Modalities

Development & manufacturing

Structured CDMO capabilities from verified public sources.

Biologics / bioreactor infrastructure

Services

Indications

About this organization

WuXi Vaccines is a subsidiary of WuXi Biologics focused on contract development and manufacturing of vaccine and prophylactic antibody products. The organization provides integrated, end-to-end solutions spanning cell line development, upstream and downstream process development, final drug product formulation, GMP manufacturing, and analytical testing.

Modalities & Platforms:

  • Mammalian: monoclonal antibodies (mAb), recombinant proteins (rProtein), nanoparticles, and virus-like particles (VLP)
  • Viral: live-attenuated and viral-vectored vaccine platforms
  • Microbial: recombinant proteins, VLP, and outer membrane vesicles (OMV)
  • Nucleic Acid: mRNA and plasmid DNA (pDNA) technologies

Regulatory & Quality: WuXi Vaccines operates multiple globally GMP-certified facilities with 7 regulatory inspections passed and 5 facilities certified as of June 2026. The organization has delivered over 550 million doses to more than 180 countries and manages over 107 projects in development.

Service Scope: Full development and manufacturing capabilities from discovery through late-stage development and commercialization, with dedicated analytical testing services. The company emphasizes CMC and regulatory expertise, quality assurance, and IP protection as core differentiators.

Locations

  • Headquarters

    Suzhou · Jiangsu · China

Similar profiles by shared services, modalities, and capabilities.

Submit a verified review for this organization.

Markdown mirror: /companies/wuxivaccines.md